Parametric Portfolio Associates LLC boosted its holdings in shares of Aetna Inc. (NYSE:AET) by 63.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,113,972 shares of the company’s stock after purchasing an additional 433,372 shares during the period. Parametric Portfolio Associates LLC owned about 0.34% of Aetna worth $169,134,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in AET. Benjamin F. Edwards & Company Inc. lifted its stake in Aetna by 9.5% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 2,033 shares of the company’s stock worth $259,000 after purchasing an additional 176 shares during the last quarter. Swiss National Bank lifted its stake in Aetna by 23.4% during the first quarter. Swiss National Bank now owns 1,472,338 shares of the company’s stock worth $187,797,000 after purchasing an additional 279,500 shares during the last quarter. Icon Advisers Inc. Co. increased its holdings in shares of Aetna by 82.1% during the first quarter. Icon Advisers Inc. Co. now owns 47,356 shares of the company’s stock worth $6,040,000 after buying an additional 21,356 shares in the last quarter. World Asset Management Inc increased its holdings in shares of Aetna by 12.6% during the first quarter. World Asset Management Inc now owns 38,294 shares of the company’s stock worth $4,884,000 after buying an additional 4,298 shares in the last quarter. Finally, UBS Asset Management Americas Inc. increased its holdings in shares of Aetna by 29.2% during the first quarter. UBS Asset Management Americas Inc. now owns 2,376,132 shares of the company’s stock worth $303,076,000 after buying an additional 537,604 shares in the last quarter. Hedge funds and other institutional investors own 89.52% of the company’s stock.

Several brokerages have recently issued reports on AET. Argus reiterated a “buy” rating and set a $185.00 price target (up from $165.00) on shares of Aetna in a report on Tuesday, September 12th. Morgan Stanley upped their price target on shares of Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $175.00 price target (up from $150.00) on shares of Aetna in a report on Wednesday, August 9th. Deutsche Bank AG upped their price target on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Finally, Jefferies Group LLC reiterated a “hold” rating and set a $163.00 price target (up from $157.00) on shares of Aetna in a report on Friday, August 4th. Seven investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $160.77.

In related news, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. 0.90% of the stock is owned by insiders.

Shares of Aetna Inc. (NYSE:AET) traded up 0.12% during mid-day trading on Friday, reaching $153.57. 3,404,871 shares of the company’s stock were exchanged. Aetna Inc. has a one year low of $104.59 and a one year high of $164.52. The stock has a market cap of $51.00 billion, a PE ratio of 34.09 and a beta of 0.53. The company has a 50 day moving average price of $157.50 and a 200-day moving average price of $145.70.

Aetna (NYSE:AET) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company had revenue of $15.52 billion for the quarter, compared to analysts’ expectations of $15.34 billion. During the same quarter in the previous year, the company earned $2.21 earnings per share. Aetna’s quarterly revenue was down 2.7% on a year-over-year basis. On average, analysts predict that Aetna Inc. will post $9.55 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This report was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.dailypolitical.com/2017/09/23/aetna-inc-aet-holdings-raised-by-parametric-portfolio-associates-llc.html.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.